Can I read Racial disparities with PRN medication usage in inpatient psychiatric treatment on EtoBox?

Racial disparities with PRN medication usage in inpatient psychiatric treatment by Areef S. Kassam; Peter Karalis; Taline Aydinian; Anita Panjwani; Gabriel Martinez; Aaron Whiteman; Magdoline Daas; E. Ann Cunningham is a Medicine article available to read on EtoBox.

What is Racial disparities with PRN medication usage in inpatient psychiatric treatment about?

## Abstract Racial disparities in psychiatric diagnoses and treatment have significant public health implications, contributing to inequities in healthcare outcomes. We specifically examined racial disparities regarding pro re nata (PRN), or as needed, medications. Data from 14,616 encounters across 2019–2020 within Community Health Network’s inpatient psychiatric setting in Indianapolis, Indiana were included in this study. Due to the demographic sample size, analyses were narrowed to Black and White patients. Primary outcomes included comparisons across race for all PRN administrations and PRN administrations of antipsychotics vs. non-antipsychotics. Logistic regression was used to examine associations between race and PRN administrations by medication category, including all antipsychotics vs. non-antipsychotics overall, hydroxyzine, and lorazepam, independently. Significant differences in the percentage of administrations between Black and White patients were observed. Black patients received more PRN medications overall (71.0%) compared to White patients (67.7%) (__p__ < 0.01). Further, while 17.7% of Black patients were administered PRN antipsychotics, this was true for only

Who reads Racial disparities with PRN medication usage in inpatient psychiatric treatment?

Author

Areef S. Kassam; Peter Karalis; Taline Aydinian; Anita Panjwani; Gabriel Martinez; Aaron Whiteman; Magdoline Daas; E. Ann Cunningham

Publisher

Nature Publishing Group UK

Published

2024

Language

EN

Field

Medicine (Health Sciences)